UW Medicine investigators are starting volunteer enrollment for a clinical trial evaluating an investigational, second-generation COVID-19 vaccine. The Phase 1 multicenter study will examine safety, tolerability, and immune response for different doses of a two-part, investigational COVID-19 vaccine regimen. The second stage of the study will include vaccines with multiple SARS-CoV-2 proteins, in addition to the components of Spike protein used in the current COVID-19 vaccines given under FDA Emergency Use Authorization.
A clinical trial has now started to assess the safety, tolerability and immune response for a new COVID-19 vaccine candidate
/Public Release. This material comes from the originating organization and may be of a point-in-time nature, edited for clarity, style and length. View in full here.